Orchid Pharma Cash Flow Annual

BSE: 524372 | NSE: ORCHPHARMA | ISIN: INE191A01027 | Sector: Biotechnology & Drugs

1,006.00 +7.30 (0.73%)Updated : 07 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Issuance( Retirement)of Debt Net	171.87	28.34	-208.55	63.39
Net Changein Cash	-14.10	17.51	-19.00	18.29
Cash Taxes Paid	-2.68	0.94	-0.63	0.30
Net Income/ Starting Line	20.36	99.46	89.05	46.32
Changesin Working Capital	54.83	-109.47	-7.21	-79.36
Cashfrom Operating Activities	101.20	19.22	125.99	18.34
Cash Interest Paid	1.89	3.11	16.35	32.23
Cashfrom Financing Activities	169.98	25.22	167.04	31.17
Depreciation/ Depletion	35.45	34.55	33.24	54.79
Other Investing Cash Flow Items Total	98.31	123.18	-247.21	53.70
Capital Expenditures	-383.58	-150.11	-64.81	-84.91
period Type	-	-	-	-
Non- Cash Items	-9.44	-5.32	10.92	-3.41
Financing Cash Flow Items	-1.89	-3.11	-16.35	-32.23
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	-285.27	-26.93	-312.03	-31.21
Issuance( Retirement)of Stock Net	-	0.00	391.94	-

*All figures in crores except per share values

Trending Stocks

2,427.00+57.00(2.41%)

1,653.95+18.95(1.16%)

3,443.60+28.60(0.84%)

1,093.40-56.50 (-4.91%)

2,007.00-82.25 (-3.94%)

Related News